Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Neutral

Price to Earnings Rating

Strong Sell

Analyst Rating

Neutral

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Standard Deviation

Strong Sell

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Sell

C

Icosavax, Inc. Common Stock (ICVX)

Biological Products, (no Disgnostic Substances)

https://www.icosavax.com

Icosavax Inc is a biopharmaceutical company. It is committed towards developing safe and effective vaccines against infectious diseases against infectious diseases, with an initial focus on life-threatening respiratory diseases.

1930 BOREN AVE., SUITE 1000
SEATTLE, WA

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/29/2021

Market Cap

769,036,610

Shares Outstanding

50,090,000

Weighted SO

50,230,993

Total Employees

N/A

Upcoming Earnings

04/04/2024

Similar Tickers

TERN --.--%

AMLX --.--%

ABOS --.--%

INZY --.--%

XFOR --.--%

DAWN --.--%

ELDN --.--%

HOOK --.--%

MREO --.--%

Beta

1.2780

Last Div

0.0000

Range

4.75-16.105

Chg

-0.1400

Avg Vol

1053296

Mkt Cap

769036610

Exch

NASDAQ

Country

US

Phone

206 737 0085

DCF Diff

14.0501

DCF

1.2599

Div Yield

0.0000

P/S

0.0000

EV Multiple

-6.7421

P/FV

3.2962

Div Yield %

0.0000

P/E

-8.2702

PEG

-0.2017

Payout

0.0000

Current Ratio

18.0589

Quick Ratio

17.5906

Cash Ratio

4.8533

DSO

0.0000

DIO

0.0000

Op Cycle

0.0000

DPO

123.1241

CCC

0.0000

Gross Margin

0.0000

Op Margin

0.0000

Pretax Margin

0.0000

Net Margin

0.0000

Eff Tax Rate

0.0571

ROA

-0.3686

ROE

-0.4124

ROCE

-0.4444

NI/EBT

0.9577

EBT/EBIT

0.9134

EBIT/Rev

0.0000

Debt Ratio

0.0321

D/E

0.0347

LT Debt/Cap

0.0247

Total Debt/Cap

0.0336

Int Coverage

38.1423

CF/Debt

-8.5302

Equity Multi

1.0814

Rec Turnover

0.0000

Pay Turnover

2.9645

Inv Turnover

0.0000

FA Turnover

0.0000

Asset Turnover

0.0000

OCF/Share

-1.3761

FCF/Share

-1.4727

Cash/Share

4.5813

OCF/Sales

0.0000

FCF/OCF

1.0702

CF Coverage

-8.5302

ST Coverage

-31.5089

CapEx Coverage

-14.2422

Div&CapEx Cov

-14.2422

P/BV

3.2962

P/B

3.2962

P/S

0.0000

P/E

-8.2702

P/FCF

-10.4374

P/OCF

-11.1257

P/CF

-11.1257

PEG

-0.2017

P/S

0.0000

EV Multiple

-6.7421

P/FV

3.2962

DPS

0.0000

Latest Headlines (EST)

Benzinga Dec 12, 14:23 Crude Oil Down 4%; Aditxt Shares Spike Higher Benzinga Dec 12, 11:58 Dow Jumps Over 100 Points; Oracle Posts Mixed Q2 Results MarketWatch Dec 12, 10:02 Here's what hit the Magnificent 7 stocks, and why the selling may continue. The Motley Fool Dec 12, 09:37 Oracle's Falling, but You Won't Want to Miss This Soaring Biotech Stock MarketWatch Dec 12, 08:37 Here's what hit the Magnificent 7 stocks, and why the selling may continue. MarketWatch Dec 12, 06:51 Here's what hit the Magnificent 7 stocks, and why the selling may continue. GlobeNewswire Inc. Dec 12, 02:05 Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca GlobeNewswire Inc. Dec 12, 02:05 Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca GlobeNewswire Inc. Dec 12, 02:05 Icosavax, Inc. Announces Agreement to be Acquired by AstraZeneca

Revenue Product Segmentation